Seeking Alpha

Hospira (HSP +3.7%) shares surge on a report that a U.S. district court invalidated...

Hospira (HSP +3.7%) shares surge on a report that a U.S. district court invalidated Sanofi-Aventis' (SNY -2.1%) patent on Taxotere, potentially opening the door for its generic version of the cancer treatment. The drug was one of Sanofi's top revenue producers, with $2.2B in sales in 2009.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs